author_facet Aggarwal, Rahul Raj
Weinberg, Vivian K.
Ryan, Charles J.
Harzstark, Andrea Lynne
Bryce, Alan Haruo
Derleth, Christina Louise
Lowe, Kimberly
Small, Eric Jay
Aggarwal, Rahul Raj
Weinberg, Vivian K.
Ryan, Charles J.
Harzstark, Andrea Lynne
Bryce, Alan Haruo
Derleth, Christina Louise
Lowe, Kimberly
Small, Eric Jay
author Aggarwal, Rahul Raj
Weinberg, Vivian K.
Ryan, Charles J.
Harzstark, Andrea Lynne
Bryce, Alan Haruo
Derleth, Christina Louise
Lowe, Kimberly
Small, Eric Jay
spellingShingle Aggarwal, Rahul Raj
Weinberg, Vivian K.
Ryan, Charles J.
Harzstark, Andrea Lynne
Bryce, Alan Haruo
Derleth, Christina Louise
Lowe, Kimberly
Small, Eric Jay
Journal of Clinical Oncology
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
Cancer Research
Oncology
author_sort aggarwal, rahul raj
spelling Aggarwal, Rahul Raj Weinberg, Vivian K. Ryan, Charles J. Harzstark, Andrea Lynne Bryce, Alan Haruo Derleth, Christina Louise Lowe, Kimberly Small, Eric Jay 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e16060 A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2014.32.15_suppl.e16060
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC5lMTYwNjA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC5lMTYwNjA
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint American Society of Clinical Oncology (ASCO), 2014
imprint_str_mv American Society of Clinical Oncology (ASCO), 2014
issn 0732-183X
1527-7755
issn_str_mv 0732-183X
1527-7755
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str aggarwal2014amulticenterphaseistudyofcabazitaxelmitoxantroneandprednisoneforchemotherapynaivepatientswithmetastaticcastrationresistantprostatecancer
publishDateSort 2014
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_unstemmed A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_full A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_fullStr A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_full_unstemmed A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_short A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_sort a multicenter phase i study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e16060
publishDate 2014
physical e16060-e16060
description
container_issue 15_suppl
container_start_page 0
container_title Journal of Clinical Oncology
container_volume 32
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792324866447245331
geogr_code not assigned
last_indexed 2024-03-01T11:56:29.804Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+multicenter+phase+I+study+of+cabazitaxel%2C+mitoxantrone%2C+and+prednisone+for+chemotherapy-naive+patients+with+metastatic+castration-resistant+prostate+cancer.&rft.date=2014-05-20&genre=article&issn=1527-7755&volume=32&issue=15_suppl&pages=e16060-e16060&jtitle=Journal+of+Clinical+Oncology&atitle=A+multicenter+phase+I+study+of+cabazitaxel%2C+mitoxantrone%2C+and+prednisone+for+chemotherapy-naive+patients+with+metastatic+castration-resistant+prostate+cancer.&aulast=Small&aufirst=Eric+Jay&rft_id=info%3Adoi%2F10.1200%2Fjco.2014.32.15_suppl.e16060&rft.language%5B0%5D=eng
SOLR
_version_ 1792324866447245331
author Aggarwal, Rahul Raj, Weinberg, Vivian K., Ryan, Charles J., Harzstark, Andrea Lynne, Bryce, Alan Haruo, Derleth, Christina Louise, Lowe, Kimberly, Small, Eric Jay
author_facet Aggarwal, Rahul Raj, Weinberg, Vivian K., Ryan, Charles J., Harzstark, Andrea Lynne, Bryce, Alan Haruo, Derleth, Christina Louise, Lowe, Kimberly, Small, Eric Jay, Aggarwal, Rahul Raj, Weinberg, Vivian K., Ryan, Charles J., Harzstark, Andrea Lynne, Bryce, Alan Haruo, Derleth, Christina Louise, Lowe, Kimberly, Small, Eric Jay
author_sort aggarwal, rahul raj
container_issue 15_suppl
container_start_page 0
container_title Journal of Clinical Oncology
container_volume 32
description
doi_str_mv 10.1200/jco.2014.32.15_suppl.e16060
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC5lMTYwNjA
imprint American Society of Clinical Oncology (ASCO), 2014
imprint_str_mv American Society of Clinical Oncology (ASCO), 2014
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 0732-183X, 1527-7755
issn_str_mv 0732-183X, 1527-7755
language English
last_indexed 2024-03-01T11:56:29.804Z
match_str aggarwal2014amulticenterphaseistudyofcabazitaxelmitoxantroneandprednisoneforchemotherapynaivepatientswithmetastaticcastrationresistantprostatecancer
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical e16060-e16060
publishDate 2014
publishDateSort 2014
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Aggarwal, Rahul Raj Weinberg, Vivian K. Ryan, Charles J. Harzstark, Andrea Lynne Bryce, Alan Haruo Derleth, Christina Louise Lowe, Kimberly Small, Eric Jay 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e16060 A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. Journal of Clinical Oncology
spellingShingle Aggarwal, Rahul Raj, Weinberg, Vivian K., Ryan, Charles J., Harzstark, Andrea Lynne, Bryce, Alan Haruo, Derleth, Christina Louise, Lowe, Kimberly, Small, Eric Jay, Journal of Clinical Oncology, A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer., Cancer Research, Oncology
title A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_full A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_fullStr A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_full_unstemmed A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_short A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_sort a multicenter phase i study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
title_unstemmed A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e16060